(Q30412634)

19 September 2017

1 reference

title

AMG 479, a novel IGF-1-R antibody, inhibits endometrial cancer cell proliferation through disruption of the PI3K/Akt and MAPK pathways (English)

1 reference

19 September 2017

1 reference

1 reference

Albert Mendivil

1

1 reference

19 September 2017

Chunxiao Zhou

2

1 reference

19 September 2017

Leigh A Cantrell

3

1 reference

19 September 2017

Paola A Gehrig

4

1 reference

19 September 2017

Kim M Malloy

5

1 reference

19 September 2017

Leen J Blok

6

1 reference

19 September 2017

Curt W Burger

7

1 reference

19 September 2017

Victoria L Bae-Jump

8

1 reference

19 September 2017

language of work or name

1 reference

1 September 2011

1 reference

19 September 2017

Reproductive Sciences

1 reference

19 September 2017

18

1 reference

19 September 2017

9

1 reference

19 September 2017

832-841

1 reference

Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.

19 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

AMG 479, a fully human anti-insulin-like growth factor receptor type I monoclonal antibody, inhibits the growth and survival of pancreatic carcinoma cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Insulin-like growth factor 1 receptor targeted therapeutics: novel compounds and novel treatment strategies for cancer medicine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

The type 1 insulin-like growth factor receptor pathway

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Diabetes and risk of endometrial cancer: a population-based prospective cohort study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

In vivo effects of the human type I insulin-like growth factor receptor antibody A12 on androgen-dependent and androgen-independent xenograft human prostate tumors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Insulin-like growth factor I stimulates telomerase activity in prostate cancer cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Autophosphorylation of the insulin-like growth factor I receptor cytoplasmic domain

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

The IGF-I receptor in cancer research

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

The role of the tyrosine kinase domain of the insulin-like growth factor-I receptor in intracellular signaling, cellular proliferation, and tumorigenesis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.

20 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1933719111398501

Insulin-like growth factor 2 and its receptors (IGF 1R and IGF 2R/mannose 6-phosphate) in endometrial adenocarcinoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1933719111398501

A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1177%2F1933719111398501

An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4046305

Association between adiponectin, insulin resistance, and endometrial cancer

26 November 2018

1 reference

12 December 2020

Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium

1 reference

12 December 2020

Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis

1 reference

12 December 2020

Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer

1 reference

12 December 2020

Identifiers

DOI

10.1177/1933719111398501

1 reference

19 September 2017

1 reference

19 September 2017

1 reference